Policies, codes and standards
At GSK, we want to ensure that everything we do is guided by our values and our commitment to being in compliance with the regulations within which we have to operate.
The foundations of these commitments are laid out in our Code of Conduct – our guiding principles to help us always do the right thing for patients and consumers, regulators and society as a whole.
GSK Code of Conduct
- Our Code of Conduct (PDF - 2.8 MB)
- Our Code of Practice for Promotion of Prescription Medicines and for Scientific Engagement (PDF - 1,857 KB)
Anti-Bribery and Corruption (ABAC) Program
The Anti-Bribery and Corruption (ABAC) Program is part of GSK’s response to the threat and risk of bribery and corruption. The program has been designed to assist internal and external parties in understanding corruption risk and identifying people’s responsibilities in actively combatting both real and perceived corruption.
- Anti-Bribery and Corruption Policy (PDF - 904 KB)
Anti-Bribery and Corruption Program Third Party Guidelines
Third Party Guidelines are provided to all third parties that GSK engages with in order to make them aware of our anti-bribery and corruption policies and what we expect from them as our business partners.
- GSK Anti-Bribery and Corruption Guidelines for Third Parties (PDF - 252 KB)
GlaxoSmithKline Inc. (GSK) is committed to understanding the current health-care environment and developing innovative solutions for tomorrow.
As a leader in the pharmaceutical industry, the company continues to seek opportunities to contribute to the health-care reform debate. And as a partner in the health-care system, GSK works toward communicating the value-added impact of innovative pharmaceuticals within an integrated health-care delivery system.
In addition, GSK works with cross-sectoral partners to strengthen and grow the innovation environment in Canada.